Lymphoseek (tilmanocept) 50 micrograms kit for radiopharmaceutical preparation: temporary extension of shelf life
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
Medicine name |
Lymphoseek
|
Active substance |
tilmanocept
|
Therapeutic area (MeSH) |
Radionuclide Imaging
|
Procedure number |
EMEA/H/C/002085
|
Regulatory outcome |
Maintenance
|
DHPC type |
Medicine shortage
|
Human ATC code |
V09IA09
|
Dissemination date |
30/05/2022
|